Pharmaceuticals

Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development

Yuvraj — Fri, 26 Jun 2026 07:23:30 +0000

Novartis has finalized a significant collaboration agreement with Antares Therapeutics to advance the discovery and development of small molecule therapies for various cancers. The deal, which could reach a total value of $1.9 billion, focuses on addressing oncology targets that have historically been categorized as undruggable. Under the terms of the agreement, Novartis will provide […]

The post Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development first appeared on World Pharma Today.

Abu Dhabi and MSD Partner to Enhance Healthcare Access via New Logistics Hub

Yuvraj — Fri, 26 Jun 2026 05:12:11 +0000

The Department of Health – Abu Dhabi (DoH) has announced a strategic collaboration with MSD to evaluate the feasibility of establishing an Abu Dhabi logistics hub. Located within the Health, Endurance, Longevity, and Medicine (HELM) Cluster, this planned facility is designed to streamline the distribution of a comprehensive portfolio of pharmaceutical products across diverse regional […]

The post Abu Dhabi and MSD Partner to Enhance Healthcare Access via New Logistics Hub first appeared on World Pharma Today.

Bayer and Iambic Collaboration Expands AI Drug Discovery Efforts

Yuvraj — Thu, 25 Jun 2026 05:47:49 +0000

Bayer has strengthened its pharmaceutical and ophthalmology portfolio through two separate transactions, completing the acquisition of Perfuse Therapeutics while also entering a collaboration agreement with Iambic Therapeutics. The moves provide Bayer with full ownership of Perfuse’s lead asset, PER-001, and expand its access to advanced artificial intelligence technologies aimed at accelerating drug development. The acquisition […]

The post Bayer and Iambic Collaboration Expands AI Drug Discovery Efforts first appeared on World Pharma Today.

AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal

Yuvraj — Wed, 24 Jun 2026 12:58:04 +0000

In a significant expansion of its research and development capabilities, a definitive agreement has been reached where AbbVie acquires Apogee Therapeutics for $10.9 billion. This strategic transaction is centered around the addition of zumilokibart, a highly anticipated IL-13 antibody, to the acquiring company’s expanding pipeline. By bringing this advanced asset in-house, the organization aims to […]

The post AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal first appeared on World Pharma Today.

Moderna Commercial Expansion Accelerates Vaccine Launches

Yuvraj — Thu, 18 Jun 2026 10:26:16 +0000

Moderna is strengthening its commercial leadership and operational structure as it prepares for a series of anticipated vaccine launches over the next several years. The company expects potential introductions of its mRNA-based seasonal flu vaccine, combined flu/COVID-19 vaccine, and norovirus vaccine between 2027 and 2028. As part of this effort, Moderna has appointed Esther Banque, […]

The post Moderna Commercial Expansion Accelerates Vaccine Launches first appeared on World Pharma Today.

Jazz AbCellera Alliance Targets Next-Generation Cancer Drugs

Yuvraj — Thu, 18 Jun 2026 09:46:59 +0000

Jazz Pharma has entered into a major collaboration with AbCellera focused on advancing cancer immunotherapy programmes, signing an agreement that could ultimately exceed $4 billion in value. Under the arrangement, the companies will work on up to five multispecific antibody-based T-cell engager (TCE) candidates targeting gastrointestinal cancers and other solid tumours. The deal includes an […]

The post Jazz AbCellera Alliance Targets Next-Generation Cancer Drugs first appeared on World Pharma Today.

Alzheimer’s Drug Packaging Expansion Receives UK Funding

Yuvraj — Wed, 17 Jun 2026 12:37:04 +0000

Eisai is moving ahead with a major upgrade of its manufacturing facility in Hatfield, Hertfordshire, backed by support from the United Kingdom’s Life Sciences Innovative Manufacturing Fund (LSIMF). The Japanese drugmaker is investing approximately 48 million pounds sterling ($64.5 million) to expand the site and introduce new cold-chain supply and packaging capabilities for medicines that […]

The post Alzheimer’s Drug Packaging Expansion Receives UK Funding first appeared on World Pharma Today.

Recipharm Investment Expands US Sterile Manufacturing

Yuvraj — Wed, 17 Jun 2026 12:29:17 +0000

Recipharm has unveiled a multi-million-dollar investment in its US operations aimed at increasing sterile fill and finish manufacturing capacity for biologics and advanced therapies. The expansion comes after the company secured a clinical biologics fill and finish agreement with a major global pharmaceutical company and is intended to broaden capabilities spanning development, scale-up, clinical production […]

The post Recipharm Investment Expands US Sterile Manufacturing first appeared on World Pharma Today.

IQVIA AI Expands Pharma Reach to NP and PA Prescribers

Yuvraj — Wed, 17 Jun 2026 10:02:06 +0000

IQVIA Digital has introduced new technology designed to help pharmaceutical marketers better identify nurse practitioners (NPs) and physician associates (PAs) who prescribe medicines, using insights obtained from POCN Group, the social and professional community for NPs and PAs that the company acquired in 2024. According to POCN data, NPs and PAs account for 35% of […]

The post IQVIA AI Expands Pharma Reach to NP and PA Prescribers first appeared on World Pharma Today.

Celltrion Expands Oncology Biosimilars Portfolio in Vietnam

Yuvraj — Mon, 15 Jun 2026 13:34:11 +0000

Celltrion has strengthened its footprint in Vietnam by introducing two oncology biosimilars, further expanding its portfolio in one of Southeast Asia’s rapidly growing pharmaceutical markets. The company announced that commercial sales of Truxima (rituximab), used in the treatment of hematologic malignancies, and Vegzelma (bevacizumab), indicated for multiple cancers including metastatic colorectal cancer and breast cancer, […]

The post Celltrion Expands Oncology Biosimilars Portfolio in Vietnam first appeared on World Pharma Today.